CRITICAL CARE OF HELLP SYNDROME WITH CORTICOSTEROIDS

ABSTRACT

HELLP syndrome is a special type of severe preeclampsia that constitutes a management dilemma for obstetricians. The high maternal and perinatal morbidity (and rarely maternal mortality) that can result from this entity mandates continuing efforts to find an effective treatment or prevention. The traditional therapy for HELLP syndrome has been meticulous medical care of the mother, vigilant fetal surveillance, and timely delivery. Proposed new therapies to permit prolongation of preterm pregnancy and fetal maturation include vasodilation therapy using fluids and antihypertensives and intensive corticosteroid therapy using intravenously administered high dose dexamethasone, usually in a dose of 10 mg every 12 hours. The latter therapy appears to improve fetal and maternal health with the added benefit of accelerating postpartum recovery from HELLP syndrome.

KEYWORD

HELLP syndrome - corticosteroids - severe preeclampsia

REFERENCES

• 1 Visser W, Wallenburg H CS. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe pre-eclampsia remote from term.  Eur J Obstet Gynecol . 1995;  63 147-154
• 2 van Pampus G M, Wolf H, Westenberg S M, van der Post A M J, Bonsel G J, Treffers P E. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with preeclampsia without HELLP syndrome.  Eur J Obstet Gynecol . 1998;  76 31-36
• 3 Martin Jr N J, Blake P G, Perry Jr G K, McCaul J F, Hess L W, Martin R W. The natural history of HELLP syndrome: patterns of disease progression and regression.  Am J Obstet Gynecol . 1991;  164 1500-1513
• 4 Sibai B M, Taslimi M M, el-Nazer A, Amon E, Mabie B C, Ryan C M. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia.  Am J Obstet Gynecol . 1986;  155 501-509
• 5 Isler C M, Rinehart B K, Terrone D A, Martin R W, Magann E F, Martin Jr N J. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome.  Am J Obstet Gynecol . 1999;  181 924-928
• 6 Abroug F, Boujdaria R, Nouira S. HELLP syndrome: incidence and maternal-fetal outcome-a prospective study.  Intensive Care Med . 1992;  18 274-277
• 7 Thiagarajah S, Bourgeois F J, Harbert Jr M G, Caudle M R. Thrombocytopenia in preeclampsia: associated abnormalities and management principles.  Am J Obstet Gynecol . 1984;  150 1-7
• 8 Clark S L, Phelan J R, Allen S H, Golde S R. Antepartum reversal of hematologic abnormalities associated with HELLP syndrome: a report of three cases.  J Reprod Med . 1986;  31 70-72
• 9 Yeast J D, Coronado S. Hepatic dysfunction, thrombocytopenia and late-onset preeclampsia: a report of three cases.  J Reprod Med . 1987;  32 781-784
• 10 Heyborne K D, Burke M S, Porreco R P. Prolongation of premature gestation in women with hemolysis, elevated liver enzymes, and low platelets: a report of five cases.  J Reprod Med . 1990;  35 53-57
• 11 Magann E F, Martin R W, Isaacs J D, Blake P G, Morrison J C, Martin Jr N J. Corticosteroids for the enhancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome.  Aust N Z J Obstet Gynaecol . 1993;  33 127-131
• 12 Magann E F, Graves G R, Roberts W E, Blake P G, Morrison J C, Martin Jr N J. Corticosteroids for enhanced fetal lung maturation in patients with HELLP syndrome: impact on neonates.  Aust N Z J Obstet Gynaecol . 1993;  33 131-135
• 13 Magann E F, Bass D, Chauhan S P, Sullivan D L, Martin R W, Martin Jr N J. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets.  Am J Obstet Gynecol . 1994;  171 1148-1153
• 14 Magann E F, Perry Jr G K, Meydrech E F, Harris R L, Chauhan S P, Martin Jr N J. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP).  Am J Obstet Gynecol . 1994;  171 1154-1158
• 15 Martin Jr N J, Perry Jr G K, Blake P G, May W A, Moore A, Robinette L. Better maternal outcomes are achieved with Dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome.  Am J Obstet Gynecol . 1997;  177 1011-1107
• 16 Tompkins M J, Thiagarajah S. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: the benefit of corticosteroids.  Am J Obstet Gynecol . 1999;  181 304-309
• 17 Heller C S, Elliott J P. High-order multiple pregnancies complicated by HELLP syndrome: a report of four cases with corticosteroid therapy to prolong gestation.  J Reprod Med . 1997;  42 743-746
• 18 Isler C M, Magann E F, Rinehart B K, Terrone D A, Bass J D, Martin Jr J N. Dexamethasone versus betamethasone for postpartum HELLP: a randomized prospective clinical trial of comparative efficacy.  Am J Obstet Gynecol . 2000;  182 Abstract 234 S87
• 19 Magann E F, Martin Jr N J. Twelve steps to optimal management of HELLP syndrome.  Clin Obstet Gynecol . 1999;  42 532-550